Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Partially-Blinded, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Adults 18 to 59 Years and Healthy Adults,60 Years/Older

NCT00192153 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00192153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00192153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Partially-Blinded, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Adults 18 to 59 Years and Healthy Adults,60 Years/Older
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2001
Completion date
October 31, 2001
Enrollment
240
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza